Member

Federico Augustovski is the current Director of Health Economic Evaluations and Technology Assessment at the Institute for Clinical Effectiveness and Health Policy (IECS), an independent non-profit organization affiliated to the University of Buenos Aires, a CONICET (National Scientific and Technical Research Council) center, and one of the few INAHTA Health Technology Assessments agencies in Latin America. He is the Director of the WHO Collaborating Centre in Health Technology Assessment and Economic Evaluations at IECS. He is a Professor of Public Health at the School of Public Health of the University of Buenos Aires, where he teaches courses for graduate and postgraduate students in Decision Sciences; Patient Reported Outcomes (PRO) Development in Health as well as Health Economic Evaluations. He was elected President of the International Society for Pharmacoeconomic and Outcome Research ISPOR (2017-2020). He is also the founding Editor in Chief for Latin America of Value in Health Regional Issues (VIHRI), the ISPOR peer reviewed journal for Latin America, Asia, and Central & Eastern Europe and Africa. He is the Director of the PAHO affiliated PROVAC Center of Excellence for decision making in vaccines. He leads a multidisciplinary team devoted to clinical and economic evaluations of new and existing preventive, diagnostic and therapeutic technologies that works doing research, education, and technical support with public and private health decision makers in Latin America. He got his Medical Degree with honors at the University of Buenos Aires (1986-1991); and he is a specialist in Family Medicine. He practiced family medicine and was a staff physician for more than 20 years at the Family and Community Medicine Division of the Hospital Italiano de Buenos Aires (the leading academic non-profit hospital in Argentina). He got his M.Sc. in Epidemiology (Harvard School of Public Health, 1997-1999). He was an Alban Scholar of the European Union in Health Economics (2003-2004) getting research and training experience at the Centre for Health Economics at York University in the UK. His research production, and publication in international peer-reviewed journals (with more than 165 PubMed indexed papers), concentrates in Health Technology Assessments, Health Economic Evaluations (i.e multicountry studies in Latin America -both model-based or individual patient level piggyback studies-, PRO and preference status measures and validation (i.e. derivation of Argentine, Uruguay or Peruvian weights for the EQ-5D, Argentine SF-36 validation, or discrete choice experiments).